(Q43569479)

24 November 2017

title

Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

T Calandra

6

0 references

author name string

V Erard

1

1 reference

24 November 2017

O Lamy

2

1 reference

24 November 2017

P-Y Bochud

3

1 reference

24 November 2017

J Bille

4

1 reference

24 November 2017

A Cometta

5

1 reference

24 November 2017

publication date

15 January 2004

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

24 November 2017

published in

1 reference

24 November 2017

volume

23

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

82-88

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-003-1060-x

24 November 2017

exact match

0 references

cites work

Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia

1 reference

12 December 2020

Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Antibiotic therapy in pneumonia: a comparative study of parenteral and oral administration of penicillin

1 reference

12 December 2020

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial

1 reference

12 December 2020

A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections

1 reference

12 December 2020

Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia

1 reference

12 December 2020

Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil

1 reference

12 December 2020

Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial

1 reference

12 December 2020

Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia

1 reference

12 December 2020

Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia

1 reference

12 December 2020

Do smoking parents seek the best advice for their asthmatic children?

1 reference

12 December 2020

Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults

1 reference

12 December 2020

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

1 reference

12 December 2020

[Diagnostic and treatment of community-acquired pneumonia in the adult. Recommendations for clinical practice. By the "Practice guidelines for community-acquired pneumonia" Work Group]

1 reference

12 December 2020

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

12 December 2020

Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia

1 reference

12 December 2020

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin

1 reference

12 December 2020

Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia

1 reference

12 December 2020

Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group

1 reference

12 December 2020

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

1 reference

12 December 2020

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

12 December 2020

Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?

1 reference

12 December 2020

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

12 December 2020

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

12 December 2020

Comparison of six different criteria for judging the acceptability of sputum specimens

1 reference

12 December 2020

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

1 reference

12 December 2020

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

12 December 2020

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia

1 reference

12 December 2020

A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia

1 reference

12 December 2020

10.1007/S10096-003-1060-X

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1024105127

0 references

1 reference